Ask Dr. Hersh
LASIk Self-Evaluation Test
LASIk Self-Evaluation Test
Hear From Our Patients LASIK
"Dr. Hersh and his staff were excellent. I would recommend the Cornea and Laser Eye Institute to anyone."
Luke Petitgout, Pro Athlete
New York Giants Football
Hear From Our Patients LASIK
LASIK Laser Eye Surgery New Jersey
The Most Advanced LASIK Technology
Bogota, Colombia - March 7-8, 2013
Dr. Hersh and a team of eye surgeons visited Bogota, Colombia to perform surgery and review patients treated with a new LASIK procedure. This procedure combines LASIK with corneal collagen crosslinking. While LASIK vision correction surgery reshapes the cornea to improve nearsightedness, farsightedness, and astigmatism, collagen crosslinking uses a combination of riboflavin (vitamin B2) and ultraviolet light to strengthen the cornea. The team visited Dr. Gustavo Tomayo who has treated many patients with this procedure.
14th International Congress on Wavefront & Presbyopic Refractive Corrections Wavefront Congress
Hollywood, Florida - February 21-24, 2013
Dr. Hersh discusses Corneal Collagen Crosslinking results and new techniques.
Global Specialty Lens Symposium
Las Vegas - January 24 - 27, 2013
"An esteemed international panel presented the top 10 complications that can occur with scleral contact lenses. Patrick Caroline, FAAO from Pacific University College of Optometry moderated a lively informative discussion that delved into problem solving techniques for situations such as edge compression, bubble formation, conjunctival prolapse and more." (Contact Lens Spectrum, Daily Update)
Dr. Hersh gives lecture at the 8th International Congress of Corneal Cross-Linking
Geneva, Switzerland - December 7,8, 2012
Dr. Hersh was invited to lecture at the International Congress of Corneal Cross-Linking. He has had the honor of lecturing at this event multiple times. He discussed U.S. Crosslinking Clinical Trials, Corneal Biomechanics in Crosslinking and Predictors of Success for Crosslinking.
The Cornea and Laser Eye Institute has been involved in U.S. FDA clinical trials since 2008. If you are interested in an evaluation to see if you qualify for CXL, please contact us at info@vision-institute.com or 201-883-0505.
2012 San Diego Specialty Contact Lens Symposium
San Diego - February 24-26, 2012
Dr. Chang was invited as a feature speaker at the San Diego Specialty Contact Lens Symposium and discussed the clinical applications of the new hybrid lens technology.
Joseph C Toland: 22nd Annual Excellence in Education Conference
Philadelphia - May 6th, 2012
Dr. Chang joined other keynote speakers in paying tribute to an inspiring educator, Joseph C Toland, M.D., who has been a great mentor to many eye care professionals. Dr. Chang presented research and surgical findings in management of irregular cornea patients.
The Association for Research in Vision and Ophthalmology (ARVO)
Fort Lauderdale - May 6-10, 2012
Dr. Chang co-authored a scientific poster for presentation at ARVO, an annual conference that attracts the world's largest gathering of international eye and vision researchers. To view poster "The Use of Hybrid Contact Lens in Keratoconus and Ectasia Patients after Intacs and Corneal Collagen Crosslinking", click here.
Dr. Hersh publishes an article in the Journal of Cataract and Refractive Surgery - "Patient subjective visual function after corneal collagen crosslinking for keratoconus and corneal ectasia." Congrats to all of the authors participation! To read the full article, please click here.
2012 Global Specialty Lens Symposium
Las Vegas - January 26-29, 2012
Dr. Chang attended the Global Specialty Lens Symposium to present "Contact Lens Treatment Options and Outcomes in Keratoconus and Corneal Ectasia Patients" as a scientific paper and "The Use of Hybrid Contact Lenses in Keratoconus and Ectasia Patients" as a poster. There were 460 attendees from 31 countries in attendance at this annual meeting. To view poster, click here.
.jpg)
At the most recent international congress on corneal collagen crosslinking, Dr. Hersh presented a paper on the results of the U.S. Corneal Collagen Crosslinking (CXL) clinical trials. Of great interest, he presented the work analyzed by the research team at the CLEI Center for Keratoconus looking at the clinical timecourse of patient outcomes. To read more about these early results from the clinical trial of collagen crosslinking for keratoconus, refer to our most recently published article, "Corneal collagen crosslinking for keratoconus and corneal ectasia: One-year results".
